Skip to main content
Gut logoLink to Gut
. 1995 Jun;36(6):918–921. doi: 10.1136/gut.36.6.918

High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis.

D K Scates 1, S Venitt 1, R K Phillips 1, A D Spigelman 1
PMCID: PMC1382633  PMID: 7615284

Abstract

Patients with familial adenomatous polyposis (FAP) develop periampullary duodenal tumours, suggesting that bile contributes to their formation. The hypothesis that bile contains carcinogens has been tested by looking for DNA adducts (markers of carcinogen exposure) in the duodenum of patients with or without FAP and by determining whether bile can produce DNA adducts in vitro. Using 32P-postlabelling to detect adducts, there was an excess (compared with unaffected patients) of DNA adducts in the duodenum of FAP patients and an excess of DNA adducts in the small bowel of rats treated with FAP bile, while bile from FAP patients formed significantly more DNA adducts in vitro than did bile from controls. In this study it is shown that the excess of adduct labelling produced by FAP bile in vitro depends on the pH of the incubate. While adduct labelling at pH 6-8 did not differ significantly between bile from six FAP patients and six controls, at pH 4-5 FAP bile, but not control bile, produced a near threefold excess of adduct labelling over that at pH 6-8. Therapy that increases duodenal pH may therefore alleviate duodenal polyposis.

Full text

PDF
918

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gupta R. C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6943–6947. doi: 10.1073/pnas.81.22.6943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Offerhaus G. J., Giardiello F. M., Krush A. J., Booker S. V., Tersmette A. C., Kelley N. C., Hamilton S. R. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992 Jun;102(6):1980–1982. doi: 10.1016/0016-5085(92)90322-p. [DOI] [PubMed] [Google Scholar]
  3. Penna C., Phillips R. K., Tiret E., Spigelman A. D. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg. 1993 Aug;80(8):1027–1029. doi: 10.1002/bjs.1800800833. [DOI] [PubMed] [Google Scholar]
  4. Reddy M. V., Randerath K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 1986 Sep;7(9):1543–1551. doi: 10.1093/carcin/7.9.1543. [DOI] [PubMed] [Google Scholar]
  5. Scates D. K., Spigelman A. D., Nugent K. P., Phillips R. K., Venitt S. DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis. 1993 Jun;14(6):1107–1110. doi: 10.1093/carcin/14.6.1107. [DOI] [PubMed] [Google Scholar]
  6. Scates D. K., Spigelman A. D., Phillips R. K., Venitt S. DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis. 1992 Apr;13(4):731–735. doi: 10.1093/carcin/13.4.731. [DOI] [PubMed] [Google Scholar]
  7. Scates D. K., Spigelman A. D., Venitt S. Bile acids do not form adducts when incubated with DNA in vitro. Carcinogenesis. 1994 Dec;15(12):2945–2948. doi: 10.1093/carcin/15.12.2945. [DOI] [PubMed] [Google Scholar]
  8. Spigelman A. D., Scates D. K., Venitt S., Phillips R. K. DNA adducts, detected by 32P-postlabelling, in the foregut of patients with familial adenomatous polyposis and in unaffected controls. Carcinogenesis. 1991 Sep;12(9):1727–1732. doi: 10.1093/carcin/12.9.1727. [DOI] [PubMed] [Google Scholar]
  9. Spigelman A. D., Talbot I. C., Penna C., Nugent K. P., Phillips R. K., Costello C., DeCosse J. J. Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol. 1994 Aug;47(8):709–710. doi: 10.1136/jcp.47.8.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Spigelman A. D., Williams C. B., Talbot I. C., Domizio P., Phillips R. K. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989 Sep 30;2(8666):783–785. doi: 10.1016/s0140-6736(89)90840-4. [DOI] [PubMed] [Google Scholar]
  11. Watson W. P. Post-radiolabelling for detecting DNA damage. Mutagenesis. 1987 Sep;2(5):319–331. doi: 10.1093/mutage/2.5.319. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES